Latest in US

STAT+: Roivant says closely watched immune drug succeeded in new eye disease

An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis.

Psychologist Adam Grant Reveals 3 Tell-Tale Signs You’re Connecting With Someone on a Deeper Level

Adam Grant, Ph

Nigeria identifies travel-related Ebola case

Nigeria has confirmed an imported Ebola case tied to the ongoing outbreak centered in the Democratic Republic of the Congo, becoming the fifth country to identify a related…

Stacking supplements without key test can do more harm than good, expert warns

Jim LaValle explains why a blood test should come before buying ashwagandha, magnesium or zinc supplements to address fatigue and other symptoms.

What You Can Learn From My Skin Cancer Diagnosis

Ten years ago, Norah was diagnosed with melanoma. It was a wakeup call that changed her relationship with the sun and made her want to shine a light on the importance of early…

Expecting a baby? 5 tips to help you prepare for pregnancy costs

The cost of having a baby is difficult to predict. The amount families pay varies widely. Here are five tips to help you prepare for the often unexpected costs of pregnancy and…

A counterintuitive way to build trust in measles vaccines and public health

Some experts say public health messaging would be more credible if it focused less on measles deaths and acknowledged that most children survive.

STAT+: Mark Cuban wants to crack open the market for rare disease treatments

Mark Cuban's Cost Plus Drugs says it can reduce manufacturing costs for custom rare disease drugs and n-of-1 gene therapies.

Opinion: Replication is necessary even if scientists do everything right

“Committing a Type 1 error does not reflect poorly on the quality of the science done,” writes Mark Louie F. Ramos

Opinion: How knocking on doors can help beat measles — again

“As measles outbreaks spread in the U.S., it may be time to learn how other countries get their outbreaks under control,” writes Raj Panjabi.

STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved

After a quarter century of work, the German biotech Immatics is facing a pivotal moment as it awaits Phase 3 results for its lead candidate in melanoma.

Common disorder linked to 70% higher death rate, but medication may offer protection

ADHD medication was tied to a 25% lower mortality risk in a JAMA Network Open review examining nearly 16 million people across three continents.

Influencers are helping 'free birth' gain fans, despite medical risks

The practice known as "free birth" — giving birth at home without a midwife — carries severe risks. But social media influencers are bringing attention and followers to the…

STAT+: He’s slashing quality at nursing homes. This state is letting it happen

The Boston Globe Spotlight Team found Eli Mirlis made grim cuts to resident care while steering millions of dollars from his nursing homes’ revenue into a constellation of real…

STAT+: State regulators move to seize licenses from nursing home chain that was focus of Boston Globe investigation

A Boston Globe investigation found that RegalCare acquired nursing homes across Massachusetts, then gutted the quality of care.

A Viral Video Claims Blowing Bubbles on the Toilet Can Help You Poop. A GI Doc Reveals If It’s True

In a viral video, a physical therapist said blowing bubbles can help you poop. A gastroenterologist weighed in on whether it really works and how to do it right.